drugset / Trial / NCT03581409

Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm

NCT03581409

RandomizedParallel-groupOpen-labelTreatment

Summary

Perform a randomized comparison study of dual-antiplatelet (aspirin, prasugrel) and triple-antiplatelet (aspirin, clopidogrel, and cilostazol) preparation using P2Y12 assay in patients with high on-treatment platelet reactivity undergoing stent-assisted coil embolization for an unruptured intracranial aneurysm

Timeline

Start
2018-10-24
Primary completion
2021-01-22
Completion
2021-01-22

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cilostazol Small molecule 200 mg
Subject Clopidogrel Small molecule 75 mg
Subject Prasugrel Small molecule 5 mg
Background Aspirin Small molecule 100 mg

Indications